Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma

被引：0
|
作者：
Tsin, Andre
Chen, Chih
Serante, Alexandre Ruggieri
Ayres, Aline Sgnolf
Tonaki, Juliana Ono
Moreno, Raquel Andrade
Shih, Helen
Gattas, Gabriel Scarabotolo
Veronica, Rossana
Reis, Gabriela
Thiago, Icaro
Carvalho, Rodrigo
Nader, Gustavo
Feher, Olavo
Neto, Hugo Sterman
Neville, Iuri Santana
Moutinho, Karina Gondim
Lepine, Henrique
Oliveira, Gustavo
Figueiredo, Eberval G.
Weltman, Eduardo
机构：
来源：
NEUROSURGERY | 2025年 / 71卷
关键词：
D O I：
10.1227/neu.0000000000003360_2090
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2090
引用
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [21] Phase 2 Trial of Accelerated, Hypofractionated Whole-Breast Irradiation of 39 Gy in 13 Fractions Followed by a Tumor Bed Boost Sequentially Delivering 9 Gy in 3 Fractions in Early-Stage Breast Cancer
    Kim, Ja Young
    Jung, So-Youn
    Lee, Seeyoun
    Kang, Han-Sung
    Lee, Eun Sook
    Park, In Hae
    Lee, Keun Seok
    Ro, Jungsil
    Lee, Nam Kwon
    Shin, Kyung Hwan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05): : 1037 - 1042
  • [22] Phase 1/2 Study of Urethral and Rectal Sparing Following Extreme Hypofractionated (5x9 Gy) Stereotactic Body Radiation Therapy in Prostate Cancer
    Greco, C.
    Pares, O.
    Pimentel, N.
    Louro, V.
    Stroom, J.
    Viera, S.
    Mateus, D.
    Fuks, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S34 - S35
  • [23] Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment Response
    Myrehaug, Sten
    Hudson, John
    Soliman, Hany
    Ruschin, Mark
    Tseng, Chia-Lin
    Detsky, Jay
    Husain, Zain
    Keith, Julia
    Atenafu, Eshetu G.
    Maralani, Pejman
    Heyn, Chris
    Das, Sunit
    Lipsman, Nir
    Sahgal, Arjun
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : 342 - 350
  • [24] Adverse late effects in a prospective phase I-II trial of hypofractionated radiotherapy (66Gy/22 fractions) for localized adenocarcinoma of the prostate
    Sia, M.
    Menard, C.
    Rosewall, T.
    Bayley, A.
    Bristow, R.
    Chung, P.
    Crook, J.
    Gospodarowicz, M.
    McLean, M.
    Milosevic, M.
    Warde, P.
    Catton, C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S70 - S71
  • [25] CCTG SC.24/TROG 17.06: A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases
    Sahgal, A.
    Myrehaug, S. D.
    Siva, S.
    Masucci, L.
    Foote, M. C.
    Brundage, M.
    Butler, J.
    Chow, E.
    Fehlings, M. G.
    Gabos, Z.
    Greenspoon, J.
    Kerba, M.
    Lee, Y. K.
    Liu, M. C.
    Maralani, P.
    Thibault, I.
    Wong, R.
    Hum, M.
    Ding, K.
    Parulekar, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05): : 1397 - 1398
  • [26] A prospective study of non-coplanar conformal radiotherapy for stage INSCLC using 75Gy/25 fractions/5 weeks regimen
    Karasawa, K.
    Hanyu, N.
    Okamoto, M.
    Chang, T.
    Yoshida, D.
    Kuga, G.
    Kiguchi, Y.
    Kageyama, A.
    Itazawa, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S154 - S155
  • [27] Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
    Falk Roeder
    Carmen Timke
    Ladan Saleh-Ebrahimi
    Lutz Schneider
    Thilo Hackert
    Werner Hartwig
    Annette Kopp-Schneider
    Frank W Hensley
    Markus W Buechler
    Juergen Debus
    Peter E Huber
    Jens Werner
    BMC Cancer, 12
  • [28] Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 x 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
    Roeder, Falk
    Timke, Carmen
    Saleh-Ebrahimi, Ladan
    Schneider, Lutz
    Hackert, Thilo
    Hartwig, Werner
    Kopp-Schneider, Annette
    Hensley, Frank W.
    Buechler, Markus W.
    Debus, Juergen
    Huber, Peter E.
    Werner, Jens
    BMC CANCER, 2012, 12
  • [29] Phase 1 Study of Increased Dose-per-Fraction Hypofractionated Radiation Therapy Following Radical Prostatectomy: Toxicity Assessment of 15 Fractions at 3.6 Gy per Fraction
    Ballas, L. K.
    Aron, M.
    Chung, E.
    Shuryak, I.
    Dorff, T. B.
    Yang, D.
    Brenner, D. J.
    Groshen, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E276 - E276
  • [30] 5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial
    Poppe, Matthew M.
    Yehia, Zeinab A.
    Baker, Christopher
    Goyal, Sharad
    Toppmeyer, Deborah
    Kirstein, Laurie
    Chen, Chunxia
    Moore, D. F.
    Haffty, Bruce G.
    Khan, Atif J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (04): : 694 - 700
12345